Q1 2020

Filed May 21, 2020 · 10-Q · 51 days after period end · 0001564590-20-026574

Q1 2020 · 10-Q

Revenue

$7.08M

no prior Q1 2019 on file

Net Income

-$7.48M

N/M vs Q1 2019

EPS Diluted

-$0.22

N/M vs Q1 2019

Operating Income-$8,033,000N/M

Operating Cash Flow

Same quarter

Metric	Q1 2020	Q1 2019	Q1 2018	Q1 2017
Revenue	$7.08M	—	—	$16.00K
Net Income	-$7.48M	-$11.34M	-$3.76M	-$7.52M
EPS Diluted	-$0.22	-$0.42	-$0.21	-$0.43

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Xenon Pharmaceuticals Inc. · CIK 1582313 · Engraved from SEC EDGAR